Ad is loading...
GFVAX
Price
$17.49
Change
+$0.12 (+0.69%)
Updated
Nov 22 closing price
VFINX
Price
$551.85
Change
+$1.93 (+0.35%)
Updated
Nov 22 closing price
Ad is loading...

GFVAX vs VFINX

Header iconGFVAX vs VFINX Comparison
Open Charts GFVAX vs VFINXBanner chart's image
Goldman Sachs Focused Value A
Price$17.49
Change+$0.12 (+0.69%)
VolumeN/A
CapitalizationN/A
Vanguard 500 Index Investor
Price$551.85
Change+$1.93 (+0.35%)
VolumeN/A
CapitalizationN/A
GFVAX vs VFINX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GFVAX vs. VFINX commentary
Nov 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GFVAX is a StrongBuy and VFINX is a StrongSell.

FUNDAMENTALS
Fundamentals
VFINX has more cash in the bank: 1.28T vs. GFVAX (58.5M). VFINX pays higher dividends than GFVAX: VFINX (1.24) vs GFVAX (1.13). GFVAX was incepted earlier than VFINX: GFVAX (9 years) vs VFINX (48 years). GFVAX is a more actively managed with annual turnover of: 82.00 vs. VFINX (2.00). VFINX has a lower initial minimum investment than GFVAX: VFINX (0) vs GFVAX (1000). GFVAX annual gain was more profitable for investors over the last year : 32.46 vs. VFINX (30.57). VFINX return over 5 years is better than : 91.24 vs. GFVAX (56.21).
GFVAXVFINXGFVAX / VFINX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence9 years48 years-
Gain YTD23.27925.01193%
Front LoadN/AN/A-
Min. Initial Investment10000-
Min. Initial Investment IRAN/AN/A-
Net Assets58.5M1.28T0%
Annual Yield % from dividends1.131.2491%
Returns for 1 year32.4630.57106%
Returns for 3 years16.3627.0760%
Returns for 5 years56.2191.2462%
Returns for 10 yearsN/A189.02-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ITOS8.130.28
+3.57%
iTeos Therapeutics
CNC60.351.25
+2.12%
Centene Corp
SKY100.081.94
+1.98%
Champion Homes Inc
CNNE20.770.23
+1.12%
Cannae Holdings
CLDI2.15-0.14
-6.11%
Calidi Biotherapeutics